Plant source for HIV microbicide
Thursday, 02 April, 2009
US researchers have reported that transgenic tobacco plants can produce large quantities of griffithsin, a potent inhibitor of HIV entry into cells.
Griffithsin, derived from the red algae Griffithsia, is being studied as a potential element in vaginal microbicides, to prevent HIV from infecting mucosal surfaces.
However, the chemical has proven very difficult to synthesise. Now, researchers from the UK and the US, lead by Kenneth Palmer and Barry O’Keefe, have transduced Nicotiana benthamiana with a tobacco mosaic virus vector expressing the protein.
The plant-derived protein has been shown to have broad spectrum activity against HIV clades A, B and C, and also has been shown to no irritating and or inflammatory effects on cervical cells and in an animal model.
In a paper published in the Proceedings of the National Academy of Sciences, the researchers show they can manufacture enough griffithsin for use in a clinical trial.
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies....
Cancer research and clinical trials at the core of new centre
The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) has been...
Potential biological targets for vascular dementia
Caused by damage to blood vessels in the brain, there is currently no approved treatment for...
